span class="inline inline-left">PHOTO: COURTESY OF SILOAM HOSPITALS LIPPO VILLAGE“Patients suffering from autoimmune diseases no longer need weeks or months of ...
Apheresis therapy can be widely beneficial in treating patients with the novel coronavirus, the president of the World Apheresis Association said Wednesday. Speaking on convalescent plasma therapy, ...
PARIS, FRANCE and TARRYTOWN, NY — Adding the proprotein convertase subtilisin kexin 9 (PCSK9) inhibitor alirocumab (Praluent, Sanofi/Regeneron Pharmaceuticals) biweekly injection to standard treatment ...
Bendamustine treatment before apheresis is known to reduce survival in large B-cell lymphoma (LBCL) patients receiving chimeric antigen receptor (CAR) T-cell therapy. Bendamustine has been shown to ...
Apheresis, the simple process of drawing blood, becomes a powerful therapeutic in extracorporeal photopherisis (ECP) according to clinicians and scientists. In the case of ECP, investigators' ...
The Renal Therapies Division of B. Braun Medical Inc. (B. Braun) announced today the availability of the Plasmat™ Futura System for H.E.L.P.® LDL Apheresis therapy. This addition to B. Braun's ...
LAS VEGAS — Lipid apheresis can significantly reduce lipoprotein(a) levels compared with available drug therapies, according to a presentation at National Lipid Association Scientific Sessions.
Results from a Phase 3 clinical trial, ODYSSEY ESCAPE, evaluating Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi' s (SNY) Praluent (alirocumab) Injection in patients with heterozygous familial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback